Mersana Therapeutics (United States)

Statistics

Publications

149

Citations

14.8K

Authors

Location

Cambridge, United States

Mersana Therapeutics (United States) is a company institution in Cambridge, United States known for oncology, pharmacology, and antibody-drug conjugates.

Homepage ROR

Top concepts

Antibody-drug ConjugatesOncologyAntibody-drug Conjugate TherapyPharmacyAntibody ConjugatesAntibody ConjugationPharmacologyTargeted Cancer TherapyDrug DeliveryCancer Immunotherapy

Publications

149

Single-vector inducible lentiviral RNAi system for oncology target validation

Dmitri Wiederschain, W Nicolson Susan, Lin Chen et al. · Cell Cycle · 2009 · 461 citations · Full text

Life Sciences, Molecular Biology, Oncology +12

Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial

Ingo K. Mellinghoff, Min Lu, Patrick Y. Wen et al. · Nature Medicine · 2023 · 219 citations · Full text

Medicine, Oncology, Pharmacology +17

Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials

Joan B. Mannick, Grace Sock Leng Teo, Bernardo Patti et al. · The Lancet Healthy Longevity · 2021 · 111 citations · Full text

Life Sciences, Immunology, Pharmacology +17

A Polymer-Based Antibody–Vinca Drug Conjugate Platform: Characterization and Preclinical Efficacy

Alexander V. Yurkovetskiy, Mao Yin, Natalya D. Bodyak et al. · Cancer Research · 2015 · 100 citations

Pharmacy, Oncology, Pharmacology +17

Dolaflexin: A Novel Antibody–Drug Conjugate Platform Featuring High Drug Loading and a Controlled Bystander Effect

Aleksandr V. Yurkovetskiy, Natalya D. Bodyak, Mao Yin et al. · Molecular Cancer Therapeutics · 2021 · 75 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

1–5 of 149

Authors

TB
Timothy B. Lowinger
Mersana Therapeutics (United States), United States
211 publications · 3.9K citations
26
h-index
MD
Marc Damelin
Mersana Therapeutics (United States), United States
196 publications · 2.8K citations
23
h-index
RM
Rebecca Mosher
Mersana Therapeutics (United States), United States
123 publications · 2.3K citations
23
h-index
CC
Chen‐Ni Chin
Mersana Therapeutics (United States), United States
38 publications · 2.1K citations
17
h-index
LQ
LiuLiang Qin
Mersana Therapeutics (United States), United States
152 publications · 2.2K citations
17
h-index

1–5 of 46